Get an alert when QUANTUM PHARMACEUTICAL LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

£10m

+205.3% highest in 6 filed years

Net assets

£27m

+12% highest in 6 filed years

Employees

279

+11.6% highest in 6 filed years

Profit before tax

£8.6m

-24.1% first positive since 2020

Watch the reel

Our short-form breakdown of QUANTUM PHARMACEUTICAL LIMITED's latest filing

Quantum Pharmaceutical added £34m to its top line, but a rising cost base meant profit actually went backwards. 💊📊

Accounts

6-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31

Metric Trend 2020-06-302021-12-312022-12-312023-12-312024-12-312025-12-31 Δ vs prior
Turnover £60,979,753£120,339,373£118,967,432£174,834,631£200,387,281£234,638,280 +17.1%
Operating profit -£9,588,962£2,489,568—£16,987,068£12,349,880£10,002,132 -19%
Profit before tax -£9,732,857£15,707,557£6,948,146£15,983,242£11,304,361£8,577,146 -24.1%
Net profit ———£13,083,591£9,857,608£6,750,018 -31.5%
Cash £1,980,083£3,455,540£678,180£3,469,031£3,317,539£10,127,152 +205.3%
Total assets less current liabilities ———£20,574,125£29,279,687£33,644,770 +14.9%
Net assets ———£15,421,960£23,779,568£26,629,586 +12%
Equity -£3,100,233£4,535,592£4,688,369£15,421,960£23,779,568£26,629,586 +12%
Average employees 220208218276250279 +11.6%
Wages £6,039,392£8,361,678£6,016,737£8,227,011£8,230,775£10,348,597 +25.7%
Directors' remuneration £151,263£370,579£0——— —

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2020-06-302021-12-312022-12-312023-12-312024-12-312025-12-31
Operating margin -15.7%2.1%—9.7%6.2%4.3%
Net margin ———7.5%4.9%2.9%
Return on capital employed ———82.6%42.2%29.7%
Gearing (liabilities / total assets) ———76.2%68.2%67.7%
Current ratio ———1.23x1.36x1.37x
Interest cover ———16.92x11.81x7.01x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Name history

Renamed 1 time since incorporation

  1. QUANTUM PHARMACEUTICAL LIMITED 2010-11-19 → present
  2. QUANTUM SPECIALS LIMITED 2004-09-24 → 2010-11-19

Audit & accounting basis

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Auditor
Dains Audit (Scotland) Limited
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The directors have at the time of approving the financial statements, a reasonable expectation that the Company and the group of which the Company is a member has adequate resources to continue in operational existence for the foreseeable future.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 29 resigned

Name Role Appointed Born Nationality
BARCLAY, Kenneth Edward Director 2026-02-06 Aug 1978 British
CAMPBELL, Lewis Director 2021-06-30 Apr 1993 British
DUNCAN, Stephen Peter Director 2021-07-14 Apr 1986 Scottish
Show 29 resigned officers
Name Role Appointed Resigned
EDGE, Ian Secretary 2004-09-24 2009-03-30
MILLER, Amanda Secretary 2017-11-02 2021-06-30
SCAIFE, Andrew John Secretary 2009-03-30 2010-01-29
SUCH, Martin John Secretary 2010-01-29 2015-02-24
SWINHOE, Craig Robert Secretary 2015-02-24 2017-11-02
BARKER, Michael Denis Director 2015-06-18 2015-12-01
BROWN, Catherine Jane Director 2016-03-16 2017-09-05
BRYANT, David John Director 2019-02-01 2021-06-30
BUYER, Victoria Director 2011-02-25 2011-10-07
DICKINSON, Timothy David Director 2011-02-25 2013-04-26
EDGE, Ian Director 2004-09-24 2010-09-08
FISHER, Brian James Director 2012-01-27 2017-12-22
GRANT, Gillian Margaret Director 2022-08-23 2025-02-24
HUDSON, Kevin Robert Director 2005-04-06 2009-01-31
LIDDLE, Stephen Director 2017-09-22 2018-01-12
MATTHEWS, Andrew Paul Director 2011-07-04 2019-02-01
MURRAY, Gerard Thomas Director 2017-01-23 2017-11-02
PALING, Richard John Director 2019-03-19 2021-06-30
PATTERSON, Andrew Director 2004-09-24 2009-01-31
RICHARDSON, Phillip Dudley Director 2004-09-24 2009-01-31
RIGG, Christian Alexander Director 2016-03-08 2017-01-27
SANSON, David Alan Director 2021-07-14 2022-05-30
SANSON, David Alan Director 2013-09-25 2021-06-30
SCAIFE, Andrew John Director 2009-01-31 2015-12-01
SUCH, Martin John Director 2010-01-29 2016-03-08
SWINHOE, Craig Robert Director 2015-02-24 2015-12-01
TAGG, Michael James Director 2017-12-01 2019-03-19
THOMSON, Graham Ronald Director 2017-07-06 2018-06-30
WATERS, Alison Anne Director 2004-09-24 2011-02-25

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Target Healthcare Group Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2022-07-06 Active
Target Healthcare Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2021-06-30 Ceased 2022-07-06
Quantum Pharma Group Limited Corporate entity Shares 75–100%, Voting 75–100%, Significant influence 2016-09-24 Ceased 2021-06-30

Filing timeline

Last 20 of 174 total filings

Date Type Category Description
2026-09-28 AA accounts Accounts with accounts type full PDF
2026-09-25 CS01 confirmation-statement Confirmation statement with no updates PDF
2026-02-06 AP01 officers Appoint person director company with name date PDF
2025-12-15 CH01 officers Change person director company with change date PDF
2025-12-15 CH01 officers Change person director company with change date PDF
2025-09-30 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-09-26 AA accounts Accounts with accounts type full PDF
2025-02-25 TM01 officers Termination director company with name termination date PDF
2024-11-06 CH01 officers Change person director company with change date PDF
2024-09-24 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-07-05 AA accounts Accounts with accounts type full PDF
2024-02-20 RP04CS01 confirmation-statement Second filing of confirmation statement with made up date PDF
2024-02-05 PSC05 persons-with-significant-control Change to a person with significant control PDF
2023-09-26 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-06-09 AA accounts Accounts with accounts type full PDF
2022-09-28 AA accounts Accounts with accounts type full PDF
2022-09-26 CS01 confirmation-statement Confirmation statement with no updates
2022-09-15 AP01 officers Appoint person director company with name date PDF
2022-08-22 PSC02 persons-with-significant-control Notification of a person with significant control PDF
2022-08-22 PSC07 persons-with-significant-control Cessation of a person with significant control PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
5

last 12 months

Capital events
0

last 24 months

Officers appointed
1

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page